Do your own DD. My opinions
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
New to BIEL? Welcome! Here's what you simply need to know. It's a game changer:
'Nuff said!
https://www.bielcorp.com/products/recoveryrx/
Consider buying some BIEL stock this week at this low low price.
BUY $BIEL$
New to BIEL? Welcome! Here's what you simply need to know. It's a game changer:
'Nuff said!
https://www.bielcorp.com/products/recoveryrx/
Consider buying some BIEL stock this week at this low low price.
BUY $BIEL$
Don't make waves you can't get over. BUY - BUY - BUY or BYE - BYE - BYE - BYE.
'Nuff said!
BUY $BIEL$
LOL- I see you didn’t get the memo either!
‘Nuff said!
BUY $BIEL$
Again, so very disturbing and disrespectful to a BIEL true long. By the way. In case you didn’t get the memo, paid tards and ex mods have the weekend off.
‘Nuff said!
BUY $BIEL$
Prepare for the ascent for BIEL. I know I am.
‘Nuff said!
BUY $BIEL$
Share buy back, merger, buyout etc. Only one huge deal from going up up up. Reread the good doctor’s recent statement!
‘Nuff said!!!
Very disrespectful for one of the most "liked" posters here on BIEL. Watch from JGD and learn from him.
'Nuff said!
BUY $BIEL$
WRONG AGAIN and AGAIN. Vatican City is the smallest country in the world. Not only the posts regarding BIEL are false, now the geography is suspect too.
'Nuff Said!
Patience!!! One more response from Kelly:
Post of the month award.
‘Nuff said!
Important to note from previous post;
Paul emailed this:
Non-Opioid Pain Relief Device Market Size & Emerging Trends From 2023-2030 By Key Players-Abbott Laboratories, Bayer AG, Bioelectronics Corporation, Boston Scientific Corporation
The Non-Opioid Pain Relief Device Market is the economic domain devoted to the creation, production, advertising, and distribution of Non-Opioid Pain Relief Device-related goods or services. This domain includes a wide range of businesses that are involved in the manufacture, promotion, and sale of these offerings in order to suit the needs of consumers. Several variables influence the size, scope, and dynamics of this market, including customer preferences, technological improvements, and the regulatory environment. The "Non-Opioid Pain Relief Device Market" provides a platform for businesses to compete and lead by providing solutions that meet a wide range of client needs. It plays a critical part in the overall economy, considerably contributing to expansion and prosperity.
Request PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.marketresearchintellect.com/download-sample/?rid=570659
Discover the infinite possibilities of Non-Opioid Pain Relief Device Market! We redefine excellence as an industry pioneer by providing unrivaled products and services. Our customer-centric attitude and unwavering pursuit of innovation have propelled us to the forefront. Join our pleased clients' network and discover the transforming potential of Non-Opioid Pain Relief Device Market, where growth knows no bounds. Take your company to new heights with us today!
The global Non-Opioid Pain Relief Device Market is expected to rise steadily in the next years, owing to a combination of ongoing technology advancements, rising environmental awareness, and an increasing demand for streamlined processes. To capitalize on evolving market prospects, industry participants are expected to focus on product innovation, strategic collaborations, and regional expansion.
The research study includes profiles of leading companies operating in the Non-Opioid Pain Relief Device Market :
Abbott Laboratories
Bayer AG
Bioelectronics Corporation
8/30/2023 12:51:14 PM
BUY $BIEL$
Write this down so you don’t forget;
Renova Biomed's slogan:
"For all your pain there is Actipatch®"
‘Nuff said!
BUY $BIEL$
Do you even own a dog? You’re barking up the wrong tree here Mister. Read between the lines on the good doctor’s post. Read my educational post to diddles and then, watch from me and learn from me.
‘Nuff said!
BUY $BIEL$
BUY BUY BUY. or BYE BYE BYE.
‘Nuff said!
BUY $BIEL$
That's a good one. Too funny, diddles!
Prepare for the ascent of BIEL
On another note, I do have to admit that I sure hope you don't own an animal.
'NUFF SAID!!!
BUY $BIEL$
If you don't get it, then I can't help you. Read between the lines on today's quip from the good doctor. He scolded on the BK and stated they're on track. And to me, that's a "tell." Do what you want---just trying to help. I feel like I am Batman and you are The Riddler (oops I beg your pardon), I mean The Diddler who has it right in front. I came out of retirement from blocking you. So, heed the advice.
'Nuff said!
BUY $BIEL$
I expect the next announcements(s) will be HUGE. Remember when you could buy BIEL @ .0005? You will :)
Newbies---perfect time to get in.
'Nuff said!
BUY $BIEL$
Here's my favorite part for the NON-BIELIEVERS:
GOT BIEL? 'Nuff said!
Kelly forwarded your email to me and asked if I would be
willing to respond.
It is true that we have not put out any press
releases or communicated with the shareholders in a while. However, we
are actively pursuing our announced goals of being a low cost OEM that
has a strong research program focusing on PSWT for the treatment of a
multiple number of pain related ailments and uses third partying
specialists to distribute its products into the marketplace.
As announced earlier there are three clinical trials in progress, one at
Stanford’s medical center and two at the UC San Diego medical center.
To the best of our knowledge the preliminary results look positive.
We also finished a clinical trial on canine pain and this study is now
under peer review. In addition we have been actively pursuing the
establishment of a number of new international distributor agreements.
I can assure you that our staff is working hard to bring these agreements
to positive closure. With all this said, there is really no new material
news that we can (and should) report on right now. However, please note
we have not issued any new stock since Kelly and I took leadership after
Andy’s death and the firm is still making payroll each week. Thus,
your statement that the threat of bankruptcy appears to be real isn’t
compatible with the current status of the firm. Just the opposite, it is
moving forward with a good strategy and a good tactical plan. If you
agree, stay tuned.
Richard Staelin (Chairman of the Board)
BUY $BIEL$
Hey Nas, ELTP a STRONG BUY!
'Nuff said!
https://www.barchart.com/stocks/quotes/ELTP/overview
BUY $ELTP$
You have my attention, edbi46. Any major announcement(s) and BIEL ZOOMS.
Buying five or ten million plus shares at this point, affords you skin in the game for the newbies. Got BIEL? Get BIEL!!!
‘Nuff said!
I’m not a lawyer but to me that’s libel and should be held accountable.
Shameful actually.
Exciting times ahead for my beloved BIEL. Can you just imagine the new pain act partnering with BIEL. This is the company that got all those FDA approvals with very little money. Don’t own BIEL? I would suggest getting a little taste of it next week. You won’t need a lot to make a lot in my opinion, This is definitely worth a look (newbies) for the future.
Nuff said!
BUY $BIEL$
Just a little more patience is all that’s required here folks. I was lucky to get more fours last week, but never got a nip at the threes that were briefly asked.
Get ready for future announcements and BIEL climbing the ladder big time.
‘Nuff said!
BUY $BIEL$
You’re a riot Alice. Happy to be charged
@.25 for another TARD. Oh, and you’re on ignore too.
‘Nuff said!
BUY $BIEL$
Kelly had a nice finish to end last week. Keep 'em coming Kelly!
Have a nice weekend to all BIEL longs! True BIEL longs.
'NUFF SAID!
Hey JGD, I am one of those who have stopped responding to TARDS. Frankly, that iHub "ignore button" is ingenious. If I received two bits for each DND , I would be close to a five spot.
The TRUE BIEL LONGS are united and, quite frankly, keep adding at this low low price. I know I do.
Have a nice weekend.
'Nuff said!
BUY $BIEL$
Prepare for the ascent of BIEL. I know I am.
'Nuff Said!
BUY $BIEL$
Newbies and True BIEL longs. Prepare for the ascent of BIEL. I know I am.
'Nuff said!
BUY $BIEL$
Hey srin, I started the action with a couple of 300,000 buys. Cheap shares. For now. That’s NOT going to last.
‘Nuff said!
BUY $BIEL$
Enough with you too---continuing disrespect right out of the chute from the pokey. WOW.
ON IGNORE!!!
'Nuff said!
BUY $BIEL$
WOW---if you can't see it, I can't help you.
ON IGNORE!!! C YA!!!
"Nuff said!
BUY $BIEL$
LOL-welcome back. How was Folsom? Early release program (literally)? How many times did you drop the soap? Anyway, there will be no stopping BIEL when future confirmed announcements are made.
‘Nuff said!
BUY $BIEL$
LOL, my copyrighted “‘Nuff said” has become very popular.
Hit the ignore or listen to my BIEL wisdom.
‘Nuff said!
BUY $BIEL$
https://www.barchart.com/stocks/quotes/ELTP/overview
100% buy
'NUFF SAID!
BUY $ELTP$
Patience---look to the promising future and consider buying more BIEL. I have and I do.
'Nuff said!
BUY $BIEL$
Don’t make waves you can’t get over.
Especially against my beloved BIEL.
‘Nuff said!
BUY $BIEL$